Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Datamonitor
|
$175.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Trading Report for (OCR). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Omnicare Inc Issues FY 2013 Guidance In Line With Analysts' Estimates-Conference Call
Omnicare Inc announced that for fiscal 2013, it expects revenues to be in the range of $6.1-$6.2 billion and adjusted cash based diluted earnings per share (EPS) to be in the range of $3.47-$3.57. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $6.19 billion and EPS of $3.53 for fiscal 2013.
Latest Developments for Omnicare Inc
- Omnicare Inc Reaffirms FY 2013 Guidance-Conference Call
- Omnicare Inc Raises FY 2012 EPS Guidance-Conference Call
- Omnicare Inc Announces Management Change; Increases Quarterly Cash Dividend; Approves Additional $350 Million In Share Repurchases
- Five Star Quality Care Inc Announces Completion Of Pharmacy Sale To Omnicare, Inc
Latest Key Developments in Healthcare
- Share this
- Link this
- Digg this
Follow Reuters